These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3894702)

  • 1. In vitro and in vivo activity of two second generation platinum analogs in murine bladder cancer.
    Niell HB; Herrod HG; Blatnik AF; Soloway MS
    J Urol; 1985 Aug; 134(2):399-402. PubMed ID: 3894702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II).
    Niell HB; Wood CA; Mickey DD; Soloway MS
    Cancer Res; 1982 Mar; 42(3):807-11. PubMed ID: 7199379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concentration and time of drug exposure on clonal growth of murine bladder cancer.
    Niell HB; Soloway MS; Wood CA
    Urology; 1985 Mar; 25(3):267-72. PubMed ID: 2579500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat enhances the cytotoxicity of cis-diamminedichloroplatinum(II) and its analogues cis-1,1-cyclobutane-dicarboxylato(2R)-2-methyl-1,4- butanediammineplatinum(II) and cis-diammine(glycolato)platinum in vitro.
    Takahashi I; Maehara Y; Kusumoto H; Kohnoe S; Sugimachi K
    Cancer Chemother Pharmacol; 1993; 33(1):31-5. PubMed ID: 8269586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of chemotherapy in a murine model for bladder cancer.
    Murphy GP; Pontes JE; Williams PD
    Oncology; 1984; 41(3):195-9. PubMed ID: 6539460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth characteristics of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide (FANFT)-induced mouse bladder tumor lines in a human tumor stem cell assay.
    Niell HB; Mickey DD; Soloway MS; Wood CA
    Cancer; 1982 Jan; 49(2):323-30. PubMed ID: 7032684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
    Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
    Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
    Soloway MS; Cox CE
    Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a tumor colony assay in predicting chemotherapeutic drug response in murine bladder cancer.
    Niell HB; Soloway MS; Wood CA; McCallum LW; Webster K
    Cancer; 1983 Aug; 52(4):619-25. PubMed ID: 6861100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine model for bladder cancer.
    Murphy GP; Sandberg AA; Pontes JE; Ochi H; Yoshida M; Williams PD
    Prog Clin Biol Res; 1984; 162A():177-200. PubMed ID: 6541340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro study comparing the cytotoxicity of three platinum complexes with regard to the effect of thiol depletion.
    Smith E; Brock AP
    Br J Cancer; 1988 Jun; 57(6):548-52. PubMed ID: 3044430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
    Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro.
    Cohen JD; Robins HI
    Cancer Res; 1987 Aug; 47(16):4335-7. PubMed ID: 3300964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
    Sasaki Y; Shinkai T; Eguchi K; Tamura T; Ohe Y; Ohmori T; Saijo N
    Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological approach to the platinum compounds].
    Sasaki Y
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):456-62. PubMed ID: 1313667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II.
    Ferguson PJ; Currie C; Vincent MD
    Drug Metab Dispos; 1999 Dec; 27(12):1399-405. PubMed ID: 10570020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cytotoxicity between cisplatin and second generation platinum analogs.
    Drewinko B; Yang LY; Trujillo JM
    Invest New Drugs; 1985; 3(4):335-40. PubMed ID: 3910609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the platinum analogues in bladder cancer cell lines.
    Powles T; Perry J; Shamash J; Liu W; Oliver T; Joel S
    Urol Int; 2007; 79(1):67-72. PubMed ID: 17627172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.